AZN icon

AstraZeneca

84.69 USD
+0.86
1.03%
At close Updated Oct 17, 4:00 PM EDT
Pre-market
After hours
85.00
+0.31
0.37%
1 day
1.03%
5 days
0.4%
1 month
9.01%
3 months
22.28%
6 months
25.3%
Year to date
28.55%
1 year
8.55%
5 years
61.5%
10 years
163.01%
 

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Employees: 94,300

0
Funds holding %
of 7,496 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™